Echo IQ Expands AI-Powered Heart Tech Across 36 US Hospitals

Sydney-based Echo IQ (ASX: EIQ) has secured integration agreements with ScImage and MedAxiom, bringing its AI-driven EchoSolv AS technology to 36 hospitals and cardiology clinics in the US.

AI Integration to Accelerate Market Penetration

Echo IQ is expanding its footprint in the US by embedding EchoSolv AS, its AI-based diagnostic tool for aortic stenosis (AS), into ScImage’s cloud-based medical imaging platform and MedAxiom’s cardiology networks.

Expanded distribution will further demonstrate EchoSolv AS’ ability to enhance detection rates for severe Aortic Stenosis, a key factor in Echo IQ’s pursuit of a Category I CPT code in the US market. A CPT code allows medical providers to bill insurers for specific procedures and technologies, making widespread adoption more financially viable for the consumer, thus, theoretically increasing demand for the service.

ScImage, a provider of imaging workflow solutions with over 1,200 users, will integrate EchoSolv AS into its PICOM365 platform, ensuring seamless access for physicians. MedAxiom, affiliated with the American College of Cardiology, connects Echo IQ to a large network of cardiovascular specialists, strengthening its market reach.

Echo IQ’s Chief Executive Officer, Mr Dustin Haines, said: "By integrating EchoSolv AS into ScImage’s workflow platform and deploying it across MedAxiom’s extensive network, we are ensuring that more physicians have access to innovative, AI-driven solutions to detect and manage severe aortic stenosis. This partnership further supports our approach of prioritising integrations in the lead-up to our CATIII reimbursement."

AI Adoption in Healthcare on the Rise

This rollout positions Echo IQ for wider adoption in the US healthcare market. The company is in discussions to extend EchoSolv AS to more users across ScImage’s network, potentially driving further market penetration.

The demand for AI-driven diagnostics is growing as US hospitals address rising patient volumes and clinician shortages. AI tools like EchoSolv AS improve efficiency by automating complex diagnoses, making them increasingly valuable in modern healthcare settings.

EIQ reported cash at bank of approx. A$5.3M at the end of the December quarter, 2024.